Skip to main content

Arax Advisory Partners

Position in JNJ — Johnson & Johnson

CIK 1586767 DENVER, CO

Position in JNJ

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$10,115,171
+$3,427,375 QoQ
Shares Held
41,381
+28.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Arax Advisory Partners holds $77,931,464 across 17 Drug Manufacturers - General names. JNJ ranks #3 (13.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 JNJ
Johnson & Johnson
This page
41,381 $10,115,171

All Filings in JNJ

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,115,171 41,381
2025-12-31 $6,687,796 32,316
2025-09-30 $25,909,478 139,734
2025-06-30 $3,181,477 20,828
2025-03-31 $2,780,804 16,768
2024-12-31 $2,481,823 17,161
2024-09-30 $2,508,526 15,479
2024-06-30 $2,283,164 15,621
2024-03-31 $2,414,769 15,265
2023-12-31 $2,671,475 17,044
2023-09-30 $2,692,917 17,290
2023-06-30 $2,871,275 17,347
2023-03-31 $2,677,470 17,274
2022-12-31 $3,064,524 17,348
2022-09-30 $2,850,958 17,452
2022-06-30 $2,924,477 16,475
2022-03-31 $2,825,223 15,941
2021-12-31 $2,725,316 15,931
2021-09-30 $2,565,750 15,887
2021-06-30 $2,578,181 15,650
2020-12-31 $2,441,908 15,516
2020-09-30 $2,310,022 15,516
2020-06-30 $2,276,940 16,191
2020-03-31 $2,223,833 16,959